Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Low Dose Ketamine on Cardiovascular Function
NCT04429685Phase 1Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pain, anxiety disorder and major depressive disorder (MDD) comparing Low Dose Ketamine with Saline (placebo) (2 arms). Primary endpoint: Muscle Sympathetic Nerve Activity Burst Frequency at 5 hours. Started Nov 2020; status: terminated.
02
Drugs
ketamine
03
Conditions
painanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04429685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04429685.